Obesity drugmaker BioAge targets $158 million in IPO
- Posted on September 18, 2024
- By Fortune
- 2 Views
Obesity drugmaker BioAge targets $158 million in IPO
The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday
